Evidence map›Paper›PMID 40927713›Full record

ArticleFrontiers in immunology2025

Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives.

Yanmei Liu, Ganghui Ye, Weijun Chen, Yan Ding, Shenpeng Ying, Shixiu Wu

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanmei Liu *Department of Radiation Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
Ganghui Ye *Department of Radiation Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
Weijun Chen *Department of Radiation Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
Yan DingDepartment of Radiation Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
Shenpeng YingDepartment of Radiation Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
Shixiu WuDepartment of Radiation Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We focused on a paper titled "Radiation with immunotherapy may be a double-edged sword-how can we learn from recent negative clinical trials?", which was published in

Indexed as

Immune Checkpoint InhibitorsNeoplasmsRadiosurgeryAnimalsCombined Modality TherapyDose Fractionation, RadiationHumansImmunotherapyTumor MicroenvironmentImmune Checkpoint Inhibitorsimmune checkpoint inhibitorsimmunotherapyradiosensitivitySBRTtumor microenvironment

Identifiers

PMID40927713
PMCPMC12414920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.